Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jul 12, 2024

BUY
$7.71 - $11.56 $67,763 - $101,600
8,789 Added 10.36%
93,616 $1.08 Million
Q4 2023

Jan 26, 2024

BUY
$7.71 - $11.56 $67,763 - $101,600
8,789 Added 10.36%
93,616 $1.08 Million
Q3 2023

Jul 12, 2024

BUY
$8.91 - $10.91 $34,686 - $42,472
3,893 Added 4.81%
84,827 $775,000
Q3 2023

Oct 16, 2023

BUY
$8.91 - $10.91 $34,686 - $42,472
3,893 Added 4.81%
84,827 $775,000
Q2 2023

Jul 12, 2024

BUY
$7.14 - $9.29 $577,868 - $751,876
80,934 New
80,934 $741,000
Q2 2023

Jul 12, 2023

BUY
$7.14 - $9.29 $64,617 - $84,074
9,050 Added 12.59%
80,934 $741,000
Q1 2023

Apr 18, 2023

BUY
$6.65 - $10.69 $3,185 - $5,120
479 Added 0.67%
71,884 $529,000
Q4 2022

Jan 20, 2023

BUY
$5.96 - $8.53 $141,103 - $201,947
23,675 Added 49.6%
71,405 $0
Q3 2022

Oct 21, 2022

SELL
$5.95 - $14.3 $58,815 - $141,355
-9,885 Reduced 17.16%
47,730 $294,000
Q2 2022

Aug 04, 2022

BUY
$10.6 - $13.28 $23,023 - $28,844
2,172 Added 3.92%
57,615 $684,000
Q1 2022

Apr 21, 2022

SELL
$10.37 - $12.73 $169,642 - $208,250
-16,359 Reduced 22.78%
55,443 $648,000
Q4 2021

Jan 18, 2022

BUY
$10.21 - $15.27 $52,540 - $78,579
5,146 Added 7.72%
71,802 $806,000
Q3 2021

Oct 21, 2021

SELL
$14.07 - $17.3 $373,234 - $458,917
-26,527 Reduced 28.47%
66,656 $974,000
Q2 2021

Jul 14, 2021

BUY
$16.62 - $18.94 $495,741 - $564,942
29,828 Added 47.08%
93,183 $1.62 Million
Q1 2021

Apr 19, 2021

BUY
$15.15 - $19.78 $51,525 - $67,271
3,401 Added 5.67%
63,355 $1.1 Million
Q4 2020

Feb 01, 2021

BUY
$16.86 - $19.67 $45,167 - $52,695
2,679 Added 4.68%
59,954 $1.11 Million
Q3 2020

Oct 16, 2020

BUY
$15.4 - $20.16 $17,402 - $22,780
1,130 Added 2.01%
57,275 $994,000
Q2 2020

Jul 16, 2020

SELL
$18.24 - $21.45 $58,951 - $69,326
-3,232 Reduced 5.44%
56,145 $1.02 Million
Q1 2020

Apr 20, 2020

BUY
$16.28 - $25.63 $95,645 - $150,576
5,875 Added 10.98%
59,377 $1.2 Million
Q4 2019

Jan 21, 2020

SELL
$19.57 - $23.52 $8,062 - $9,690
-412 Reduced 0.76%
53,502 $1.25 Million
Q3 2019

Oct 18, 2019

BUY
$19.85 - $22.76 $11,949 - $13,701
602 Added 1.13%
53,914 $1.08 Million
Q2 2019

Jul 08, 2019

BUY
$17.59 - $21.1 $2,093 - $2,510
119 Added 0.22%
53,312 $1.13 Million
Q1 2019

Apr 11, 2019

BUY
$18.01 - $20.11 $6,123 - $6,837
340 Added 0.64%
53,193 $1.07 Million
Q4 2018

Jan 15, 2019

BUY
$17.44 - $21.53 $14,196 - $17,525
814 Added 1.56%
52,853 $970,000
Q3 2018

Oct 25, 2018

BUY
$19.97 - $21.96 $5,132 - $5,643
257 Added 0.5%
52,039 $1.11 Million
Q2 2018

Jul 25, 2018

BUY
$20.16 - $24.68 $8,346 - $10,217
414 Added 0.81%
51,782 $1.11 Million
Q1 2018

Apr 25, 2018

BUY
$20.31 - $24.95 $3,412 - $4,191
168 Added 0.33%
51,368 $1.09 Million
Q4 2017

Feb 01, 2018

BUY
$20.99 - $23.89 $2,015 - $2,293
96 Added 0.19%
51,200 $1.17 Million
Q3 2017

Oct 24, 2017

BUY
$20.07 - $21.89 $1.03 Million - $1.12 Million
51,104
51,104 $1.12 Million

Others Institutions Holding GRFS

About Grifols SA


  • Ticker GRFS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 678,910,976
  • Market Cap $5.33B
  • Description
  • Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...
More about GRFS
Track This Portfolio

Track Cardinal Capital Management Portfolio

Follow Cardinal Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cardinal Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Cardinal Capital Management with notifications on news.